Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 21, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
July 20, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), today announced that it has entered into a long-term...
May 19, 2020 05:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces...
May 05, 2020 07:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Reports First Quarter 2020 Financial Results

First quarter revenue of $13.9 million, a decrease of 6% compared to prior year period, due to the impact of COVID-19 in ChinaGross margins expanded 270bps to 74%Ended the quarter with $166 million of...
April 29, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
April 21, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced...
March 02, 2020 07:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth quarter 2019 revenue of $18.1 million, an increase of 18% compared to the prior year periodFourth quarter 2019 gross margin of 78.3%, an increase of 410 basis points from the prior year...
February 27, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that...
February 24, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
February 20, 2020 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announces...